Changes in Signal Transduction Pathways
▶︎ Watch it animatedinteractive step-through · ~3 min · optionalA signal transduction pathway is a relay: a receptor catches the signal, hands it to a chain of relay proteins, and the last link triggers the cell's response. Because the whole thing is a chain, a change to any one component reshapes the entire outcome — the pathway is only as intact as its weakest link. The two forces that reliably change pathways are mutations, which alter the proteins the cell builds, and chemicals — drugs, toxins, and other molecules that bind a component and jam or trip its function.
The changes fall into recognizable modes. A change can switch the pathway off — a broken receptor or dead relay protein means the signal arrives but never gets through, so the response never fires. A change can lock the pathway constitutively on — a relay protein stuck in its active shape keeps firing the response even when no signal is present. Or a change can alter the response — the pathway still runs, but the cell now does something different than it should. Drugs exploit exactly these levers on purpose: an inhibitor shuts a pathway down, while an agonist mimics the signal to force it on.
Break one component of the relay and watch the whole pathway respond. A dead receptor or relay protein switches the response off; a relay protein stuck active locks it constitutively on even with no signal; other changes reroute what the cell does. Mutations and drugs are just two ways to flip these same switches.
Pathway Changes · Open the full sandbox →The mistakes here all forget that the pathway is a chain. One is imagining every change just turns a pathway off — when a stuck-active relay protein can lock a pathway constitutively on, firing the response with no signal at all, which is exactly how many cancers arise. The other is treating a pathway as if it responds to any molecule that reaches it — when a signal only acts through the specific receptor built to catch it, so which drug or mutation matters depends on which component it actually hits (U4-BIO1). Every scenario in this topic asks you to trace a single change through the relay and reason to what the cell finally does.
The work
3 ways in · any order
Lesson
Pathway Changes
›
A signal transduction pathway is a relay, so a mutation or drug that changes one component changes the whole outcome. The lesson walks the ways students misread that: assuming every change simply turns a pathway off, and forgetting that a change only matters where it actually lands on the relay. It closes with a ten-scenario applet that asks you to trace a single change — off, constitutively on, or altered response — through the pathway to what the cell does.
Diagnostic
10-item topic check
›
Ten items on changes to signal transduction pathways — that a mutation or drug only acts where it hits, through the specific component built to catch a signal (U4-BIO1); and that a change can switch a pathway off, lock it constitutively on with no signal present, or alter the cell's response (U4-BIO6). Take it cold to surface which of these are still tangled, or after the lesson to confirm they hold.
Targeted Practice
Drill a single misconception
›
Pick one of the failure modes you missed and drill it on its own. The round is adaptive: two correct in a row clears it for now and moves you to the next. Two in a row is a checkpoint, not proof: if the error resurfaces later, the misconception comes back.